Skip to content

Understanding Patient Experience and Preferences for the QT Scanner Compared to Mammography

Understanding Patient Experience and Preferences for the QT Scanner Compared to Mammography

Status
Suspended
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04057391
Enrollment
20
Registered
2019-08-15
Start date
2019-08-06
Completion date
2022-12-30
Last updated
2022-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Cancer Screening

Brief summary

This study aims to characterize patient experience, satisfaction and preference for use of the QT Scanner in comparison to mammography by directly engaging women who have experience with both technologies.

Detailed description

The objectives will be addressed by first conducting structured one-on-one interviews with about 20 women (Qualitative Phase), and then administering a web-based patient survey with quantitative measurements in about 200 women (Quantitative Phase). The current Protocol registration pertains to the first, qualitative phase of the study.

Interventions

DIAGNOSTIC_TESTQT Scanner

Diagnostic test that is repeatable, non-invasive imaging tool for the early and accurate detection of breast cancer, breast abnormalities, and musculoskeletal findings. Comparing with mammography, the QT Scanner uses harmless soundwaves to screen and diagnose the breast.

Sponsors

Analysis Group, Inc.
CollaboratorINDUSTRY
QT Ultrasound LLC
Lead SponsorINDUSTRY

Study design

Observational model
CASE_ONLY
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Healthy volunteers
Yes

Inclusion criteria

* Have used the QT Scanner * Have used mammography * Speak English * Willing to provide consent and participate in the survey

Exclusion criteria

• Excluded if all Inclusion Criteria are not met

Design outcomes

Primary

MeasureTime frameDescription
Qualitative phase: structured one-on-one interviews30 daysone-on-one interviews will be conducted by trained professionals with about 20 women

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026